These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2900534)
1. Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology. Hyman SE Psychosomatics; 1988; 29(3):254-63. PubMed ID: 2900534 [No Abstract] [Full Text] [Related]
2. Anatomic and molecular principles of psychopharmacology. A primer for psychiatrists. Heckers S; Konradi C Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):1-22. PubMed ID: 10674188 [TBL] [Abstract][Full Text] [Related]
3. [Neurotransporters : new aspects of the mechanism of action of psychotropic drugs]. Lesch KP; Beckmann H Nervenarzt; 1993 Jan; 64(1):75-9. PubMed ID: 8094894 [No Abstract] [Full Text] [Related]
4. [Dimensional approach to trans-nosographic study of psychotropic drugs]. Jouvent R Encephale; 1995 Feb; 21 Spec No 1():39-43. PubMed ID: 7729355 [No Abstract] [Full Text] [Related]
5. Recent developments in neurobiology: Part III. Effectors of transmitter action. Hyman SE Psychosomatics; 1988; 29(4):373-8. PubMed ID: 2906447 [No Abstract] [Full Text] [Related]
6. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy]. Wunderlich H; Wunderlich HP Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615 [No Abstract] [Full Text] [Related]
7. Psychopharmacology of Alzheimer's disease. Procter AW Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):191-4. PubMed ID: 8777499 [No Abstract] [Full Text] [Related]
9. The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology. Comai S; Tau M; Gobbi G J Clin Psychopharmacol; 2012 Feb; 32(1):83-94. PubMed ID: 22198449 [TBL] [Abstract][Full Text] [Related]
10. [Stimulant amino acids, glutamate receptors and pathology of the central nervous system]. Raevskiĭ KS Patol Fiziol Eksp Ter; 1990; (1):3-9. PubMed ID: 1972271 [No Abstract] [Full Text] [Related]
11. Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders. Ban TA Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):527-80. PubMed ID: 2892227 [No Abstract] [Full Text] [Related]
12. Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist. Stahl SM J Clin Psychiatry; 2003 Oct; 64(10):1145-6. PubMed ID: 14658960 [No Abstract] [Full Text] [Related]
13. Progress in psychopharmacology. Post RM; Bunney WE Curr Psychiatr Ther; 1980; 19():69-87. PubMed ID: 6109596 [No Abstract] [Full Text] [Related]
14. [The impact of molecular biology on psychiatric diseases]. Salín-Pascual RJ; Alcocer Castillejos N Rev Invest Clin; 2003; 55(2):216-9. PubMed ID: 12827930 [No Abstract] [Full Text] [Related]
15. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Hyman SE; Nestler EJ Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194 [TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin. Greenshaw AJ J Psychiatry Neurosci; 2003 Jul; 28(4):247-50. PubMed ID: 12921219 [No Abstract] [Full Text] [Related]
17. Psychotropic management of behavioral disorders after head trauma. O'Shanick GJ Psychiatr Med; 1988; 6(3):67-82. PubMed ID: 2905507 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of the pathological manifestations of higher nervous activity and the molecular biology processes of the brain in the dynamic development of experimental neuroses]. Val'dman AV Vestn Akad Med Nauk SSSR; 1987; (8):67-76. PubMed ID: 2890246 [No Abstract] [Full Text] [Related]
19. [The future of biological psychiatry]. Linnoila M Duodecim; 1985; 101(17):1732-7. PubMed ID: 2865128 [No Abstract] [Full Text] [Related]
20. [Neurotransmitters and behavioral disorders]. Allain H; Schuck S Encephale; 1998 Jul; 24 Spec No 1():34-7. PubMed ID: 9809253 [No Abstract] [Full Text] [Related] [Next] [New Search]